Skip to main content
SpringerLink
Log in

Monitoring Drug Use and Abuse: The Evolution of a Paradigm

  • Chapter
  • First Online:
Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches

  • 4383 Accesses

Abstract

Contrary to reports in the popular media that tend to focus solely on the recent problems of prescription drug abuse, our country faces two, not one, worrisome public health crises. The first is the problem of poorly treated chronic pain, and the second is the problem of prescription drug abuse. Pain clinicians do not have the luxury of focusing on only one of these two and instead have to attempt to find a balance in their practice that allows them to treat pain with controlled substances as needed and take reasonable steps to prevent drug abuse and diversion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. ABC News/USA Today/Stanford University Medical Center Poll: Pain. Broad experience with pain sparks a search for relief. 2011. Available at: http://www.abcnews.go.com/images/Politics/979a1TheFightAgainstPain.pdf. Accessed 11 Jan 2011.

  2. American Pain Foundation. Annual report. 2006. http://www.painfoundation.org/About/2006AnnualReport.pdf. Accessed 10 May 2010.

  3. McCarberg BH, Billington R. Consequences of neuropathic pain: quality-of-life issues and associated costs. Am J Manag Care. 2006;12(9 Suppl):S263–8.

    PubMed  Google Scholar 

  4. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290:2443–54.

    Article  PubMed  CAS  Google Scholar 

  5. Argoff CE. The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin J Pain. 2007;23(1):15–22.

    Article  PubMed  Google Scholar 

  6. Cicero TJ, Inciardi JA, Munoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002–2004. J Pain. 2005;6(10):662–72.

    Article  PubMed  Google Scholar 

  7. Lipman AG. Does the DEA truly seek balance in pain medicine? J Pain Palliat Care Pharmacother. 2005;19(1):7–9.

    Article  PubMed  Google Scholar 

  8. Volkow ND. Scientific research on prescription drug abuse, before the Subcommittee on Crime and Drugs, Committee on the Judiciary and the Caucus on International Narcotics Control United States Senate. 2008. Available at: http://www.drugabuse.gov/Testimony/3-12-08Testimony.html. Accessed 10 May 2010.

  9. SAMHSA. The NSDUH report: patterns and trends in nonmedical prescription pain reliever use: 2002 to 2005. Substance Abuse and Mental Health Services Administration, Department of Health and Human Services; 2007.

    Google Scholar 

  10. SAMHSA. Office of Applied Studies of the Substance Abuse and Mental Health Services Administration. Results from the 2005 National Survey on Drug Use and Health: National Findings. Department of Health and Human Services. Publication No. SMA 06–4194. Available at: http://www.oas.samhsa.gov/NSDUH/2k5NSDUH/2k5results.htm. Accessed 10 May 2010.

  11. SAMHSA. Office of Applied Studies of the Substance Abuse and Mental Health Services Administration. Results from the 2006 National Survey on Drug Use and Health: National Findings. Department of Health and Human Services. Available at: http://www.oas.samhsa.gov/nsduh/2k6nsduh/2k6Results.pdf. Accessed 10 May 2010.

  12. Cleveland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore. 1994;23(2):129–38.

    Google Scholar 

  13. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.

    Article  PubMed  CAS  Google Scholar 

  14. Stratford PW, Binkley J, Solomon P, Finch E, Gill C, Moreland J. Defining the minimum level of detectable change for the Roland-Morris questionnaire. Phys Ther. 1996;76(4):359–65.

    PubMed  CAS  Google Scholar 

  15. Akbik H, Butler SF, Budman SH, et al. Validation and clinical application of the screener and opioid assessment for patients with pain (SOAPP). J Pain Symptom Manage. 2006;32:287–93.

    Article  PubMed  Google Scholar 

  16. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112:65–75.

    Article  PubMed  CAS  Google Scholar 

  17. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med. 2005;6:432–42.

    Article  PubMed  Google Scholar 

  18. Passik SD, Weinreb HJ. Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids. Adv Ther. 2000;17:70–83.

    Article  PubMed  CAS  Google Scholar 

  19. Passik SD, Kirsh KL, Whitcomb LA, Portenoy RK, Katz N, Kleinman L, Dodd S, Schein J. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004;26(4):552–61.

    Article  PubMed  CAS  Google Scholar 

  20. Passik SD, Kirsh KL, Whitcomb LA, Schein JR, Kaplan M, Dodd S, Kleinman L, Katz NP, Portenoy RK. Monitoring outcomes during long-term opioid therapy for non-cancer pain: results with the pain assessment and documentation tool. J Opioid Manag. 2005;1(5):257–66.

    PubMed  Google Scholar 

  21. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349:1943–53.

    Article  PubMed  CAS  Google Scholar 

  22. Haythornthwaite JA, Menefee LA, Quatrano-Piacentini AL, Pappagallo M. Outcome of chronic opioid therapy for non-cancer pain. J Pain Symptom Manage. 1998;15:185–94.

    Article  PubMed  CAS  Google Scholar 

  23. Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, Royall RM, Max MB. Opioids versus antidepressants in postherpetic neuralgia. A randomized, placebo-controlled trial. Neurology. 2002;59:1015–21.

    Article  PubMed  CAS  Google Scholar 

  24. Weissman DE, Haddox JD. Opioid pseudoaddiction – an iatrogenic syndrome. Pain. 1989;36:363–6.

    Article  PubMed  CAS  Google Scholar 

  25. Pappagallo M. The concept of pseudotolerance to opioids. J Pharm Care Pain Symptom Control. 1998;6:95–8.

    Article  Google Scholar 

  26. Smith HS. Variations in opioid responsiveness. Pain Physician. 2008;11:237–48.

    PubMed  Google Scholar 

  27. Smith HS, Deer T, Staats P, Singh V, Sehgal N, Cordner H. Intrathecal drug delivery: a focused review. Pain Physician. 2008;11:S89–104.

    PubMed  Google Scholar 

  28. Zacny J, Bigelow G, Compton P, et al. College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 2003;69(3):215–32.

    Article  PubMed  Google Scholar 

  29. Edlund MJ, Steffick D, Hudson T, et al. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129(3):355–62.

    Article  PubMed  Google Scholar 

  30. Michna E, Ross EL, Hynes WL, et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage. 2004;28(3):250–8.

    Article  PubMed  Google Scholar 

  31. Coambs RB, Jarry JL, Santhiapillai AC, et al. The SISAP: a new screening instrument for identifying potential opioid abusers in the management of chronic malignant pain within general medical practice. Pain Res Manag. 1996;1(3):155–62.

    Google Scholar 

  32. Rohsenow DJ, Colby SM, Martin RA, et al. Nicotine and other substance interaction expectancies questionnaire: relationship of expectancies to substance use. Addict Behav. 2005;30(4):629–41.

    Article  PubMed  Google Scholar 

  33. Conner BT, Stein JA, Longshore D, et al. Associations between drug abuse treatment and cigarette use: evidence of substance replacement. Exp Clin Psychopharmacol. 1999;7(1):64–71.

    Article  PubMed  CAS  Google Scholar 

  34. Hahn EJ, Rayens MK, Kirsh KL, et al. Brief report: pain and readiness to quit smoking cigarettes. Nicotine Tob Res. 2006;8(3):473–80.

    Article  PubMed  Google Scholar 

  35. Jamison RN, Stetson BA, Parris WC. The relationship between cigarette smoking and chronic low back pain. Addict Behav. 1991;16(3–4):103–10.

    Article  PubMed  CAS  Google Scholar 

  36. Yunus MB, Arslan S, Aldag JC. Relationship between fibromyalgia features and smoking. Scand J Rheumatol. 2002;31(5):301–5.

    Article  PubMed  Google Scholar 

  37. Payne TJ, Stetson B, Stevens VM, et al. The impact of cigarette smoking on headache activity in headache patients. Headache. 1991;31(5):329–32.

    Article  PubMed  CAS  Google Scholar 

  38. Passik SD, Kirsh KL, Casper D. Addiction-related assessment tools and pain management: instruments for screening, treatment planning, and monitoring compliance. Pain Med. 2008;9(S2):S145–66.

    Article  Google Scholar 

  39. Fleming MF, Davis J, Passik SD. Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med. 2008;9(8):1098–106.

    Article  PubMed  Google Scholar 

  40. Wu SM, Compton P, Bolus R, et al. The addiction behaviors checklist: validation of a new clinician-based measure of inappropriate opioid use in chronic pain. J Pain Symptom Manage. 2006;32(4):342–51.

    Article  PubMed  Google Scholar 

  41. Passik SD, Webster L, Kirsh KL. Pseudoaddiction revisited: a commentary on clinical and historical considerations. Pain Manag. 2011;1(3):239–48.

    Article  Google Scholar 

  42. Passik SD, Portenoy RK, Ricketts PL. Substance abuse issues in cancer patients. Part 1: prevalence and diagnosis. Oncology (Williston Park). 1998;12(4):517–21, 524.

    CAS  Google Scholar 

  43. Office of Diversion Control. State prescription drug monitoring programs. http://www.deadiversion.usdoj.gov/faq/rx_monitor.htm.

  44. Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain. 2002;18(4 suppl):S76–82.

    Article  PubMed  Google Scholar 

  45. Wiedemer NL, Harden PS, Arndt IO, et al. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med. 2007;8(7):573–84.

    Article  PubMed  Google Scholar 

  46. Manchikanti L, Manchukonda R, Damron KS, et al. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician. 2006;9(1):57–60.

    PubMed  Google Scholar 

  47. Bethea A, Acosta M, Haller D. Role of the therapeutic alliance in the treatment of pain patients who abuse prescription opioids. “PROJECT PAIN.” NIDA (Grant #R01DA1369). In: Paper presented at: College on problems of drug dependence, Scottsdale, 17–22 June 2006.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychiatry and Anesthesiology, Vanderbilt University Medical Center, Psychosomatic Medicine, 1103 Oxford House, Nashville, TN, 37232, USA

    Steven D. Passik Ph.D.

  2. Department of Behavioral Medicine, The Pain Treatment Center of the Bluegrass, 2416 Regency Road, Lexington, KY, 40503, USA

    Kenneth L. Kirsh Ph.D.

Authors
  1. Steven D. Passik Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth L. Kirsh Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven D. Passik Ph.D. .

Editor information

Editors and Affiliations

  1. The Center for Pain Relief, Inc., West Virginia University, 400 Court Street, Suite 100, Charleston, 25301, West Virginia, USA

    Timothy R. Deer

  2. Stanford Pain Management Center, Redwood City, CA, Clinic Chief, Stanford University School of Medicine, Stanford, 94065, California, USA

    Michael S. Leong

  3. Department of Anesthesiology, Rush Medical College, Professor, Rush University Medical Center, Chicago, 60612, Illinois, USA

    Asokumar Buvanendran

  4. Pennsylvania State University, College of Medicine, Department of Anesthesiology, Milton S. Hershey Medical Center, Hershey, 17033-0850, Pennsylvania, USA

    Vitaly Gordin

  5. Center for Interventional Pain and Spine, Newark, DE USA, Medical Director, Bryn Mawr Hospital, Bryn Mawr, 19010, Pennsylvania, USA

    Philip S. Kim

  6. President, National Institute of Pain, Tampa, 33558, Florida, USA

    Sunil J. Panchal

  7. The LITE Center, Clinical Associate Professor, Medical Director, School of Medicine, Miami, 33143, Florida, USA

    Albert L. Ray

Rights and permissions

Reprints and permissions

Copyright information

© 2013 American Academy of Pain Medicine

About this chapter

Cite this chapter

Passik, S.D., Kirsh, K.L. (2013). Monitoring Drug Use and Abuse: The Evolution of a Paradigm. In: Deer, T., et al. Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1560-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-1560-2_16

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-1559-6

  • Online ISBN: 978-1-4614-1560-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation